Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1997 | 12-1996 | 09-1996 | 06-1996 | 03-1996 | |
Sales | 6,214 | 6,545 | 6,221 | 6,158 | 5,189 |
Cost of Goods | 493 | N/A | 0 | 0 | N/A |
Gross Profit | 5,720 | 6,545 | 6,222 | 6,158 | 5,189 |
Operating Expenses | 10,234 | 0 | 10,581 | 9,914 | 0 |
Operating Income | -4,020 | 6,545 | -4,360 | -3,756 | 5,189 |
Interest Expense | 208 | 0 | 214 | 227 | 0 |
Other Income | -1,701 | 0 | -4,315 | -3,642 | 0 |
Pre-tax Income | -5,929 | 6,545 | -8,889 | -7,625 | 5,189 |
Net Income Continuous | -5,929 | -8,143 | -8,889 | -7,625 | -7,767 |
Net Income | $-5,929 | $-8,143 | $-8,889 | $-7,625 | $-7,767 |
EPS Basic Total Ops | -0.23 | -0.32 | -0.35 | -0.31 | -0.35 |
EPS Basic Continuous Ops | -0.23 | -0.32 | -0.35 | -0.31 | -0.35 |
EPS Diluted Total Ops | -0.23 | -0.32 | -0.35 | -0.31 | -0.35 |
EPS Diluted Continuous Ops | -0.23 | -0.32 | -0.35 | -0.31 | -0.35 |
EBITDA(a) | $-2,819 | $8,111 | $-2,912 | $-3,756 | $5,189 |